Vr Adviser, LLC Pharvaris N.V. Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Vr Adviser, LLC holds 3,112,720 shares of PHVS stock, worth $56 Million. This represents 11.8% of its overall portfolio holdings.
Number of Shares
3,112,720
Previous 3,220,130
3.34%
Holding current value
$56 Million
Previous $61.7 Million
20.83%
% of portfolio
11.8%
Previous 10.19%
Shares
8 transactions
Others Institutions Holding PHVS
# of Institutions
50Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$136 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$79.4 Million78.82% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$77.2 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$65.8 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$59.5 Million17.41% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $608M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...